Ascensus Specialties today announced the appointment of Dr. Emma Sceats as Chief Executive Officer, effective immediately, succeeding Paul Burlingame, who will transition to an advisory role supporting the Board and leadership team.

ZEISS today introduced ZEISS VersaXRM 5 Insight, a hybrid 3D X-ray microscope designed to help researchers and engineers understand samples faster.

Researchers found that mice later classified as resilient showed stronger coordination between neuronal OFF-periods and slow-wave activity in the prelimbic cortex even before social stress. After social defeat, resilient mice also showed a distinct reorganization of neuronal silence during NREM sleep, linking local sleep dynamics with behavioral resilience.

Medical assistance can help women suffering from severe nausea and vomiting during pregnancy, but insufficient recognition of Hyperemesis gravidarum (HG) means that many are not getting the help they need to overcome this severe and debilitating form of morning sickness.

Siemens Healthineers announced today that the automated hemostasis analyzers for mid- and high-volume laboratories are now available for patient testing in the United States.

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have developed a new, noninvasive way to examine how blood flow and cellular organization align across the layers of the living human brain.

Many women usually say the same thing during pregnancy: they walk into a room and forget why, misplace their keys or struggle to follow a conversation.

A groundbreaking study reveals that your genes may make you more vulnerable to Post Traumatic Stress Disorder (PTSD) from certain types of trauma-particularly childhood neglect-than from others.

The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs may also help to slow decline in kidney function in people with type 2 diabetes and albuminuria (high protein levels in the urine), finds a large US study published by The BMJ today.

The cancer journey for many patients doesn’t end after treatment. Many live with long-term side effects that affect their ability to sleep and cause pain, impacting daily life.

An elevated PSA level in the blood may indicate prostate cancer, but does not yet allow for a definitive diagnosis.

Today, the American Association for Cancer Research (AACR) released the 16th edition of its annual Cancer Progress Report.

Cells from nine "super donors" are being collected in Oslo. The aim is for these to be used to repair or replace damaged cells, tissue and organs in people suffering from conditions ranging from heart attacks to Parkinson's disease.

A new technology that allows vaccines to be stored at room temperature in liquid form could tackle global health inequalities.

The International Respiratory Coalition (IRC) has updated its Lung Facts platform with the latest evidence on the burden of respiratory disease across 21 countries, providing policymakers, clinicians and patient advocates with updated data to drive national-level policy action on lung health.

The mammalian gut microbiome is teeming with a delicate balance of bacteria and the viruses that keep them in check, called bacteriophages, or phages.

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the country, led the development of a new, investigational blood test that could detect pancreatic cancer at its earliest stages, when the disease is more treatable and potentially curable.

A new study illuminates the connection between the Epstein-Barr virus (EBV) and multiple sclerosis (MS), pointing to a causal role for reactivation of the virus in triggering MS attacks in people with certain genetic risk factors.

Less than a second. That’s how long it takes for an emerging AI tool to detect signs of endometriosis through one simple scan. It’s a much faster process than the current seven-year wait for surgery and less invasive.

Scandinavian Real Heart AB (publ) announces today that a study sponsored by the company has been published in the peer-reviewed journal Nature Scientific Reports, showing that the Realheart® TAH causes about six times less blood damage (hemolysis) than the only FDA-approved artificial heart device currently in wide clinical use.